Just not a lot happening with ONCX right now volume wise. I like some of the new additions to the company but people want news in the clinical trials. Which is totally understandable.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.